Press release
Subarachnoid Hemorrhage (SAH) Market Expands as Minimally Invasive Neurosurgery, Advanced Diagnostics, and Critical-Care Therapies Improve Survival
Subarachnoid Hemorrhage
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72076
Keyword Definition
Subarachnoid Hemorrhage (SAH) is a life-threatening bleeding event occurring in the subarachnoid space between the brain and surrounding membrane. SAH is categorized into:
• Aneurysmal SAH: Caused by rupture of a cerebral aneurysm (majority of severe cases).
• Non-aneurysmal SAH: Due to trauma or other non-rupture causes.
Clinical management focuses on:
• Rapid CT/CTA/MRI diagnosis
• Endovascular coiling or surgical clipping to secure the aneurysm
• ICU management to prevent vasospasm, rebleeding, hydrocephalus, and delayed cerebral ischemia
• Medications such as calcium-channel blockers, vasodilators, anticoagulant reversal agents
• Monitoring tools including intracranial pressure (ICP) systems and cerebral blood flow devices
Market Size, CAGR and Outlook
Recent consolidated estimates indicate:
• The global Subarachnoid Hemorrhage treatment market is valued at USD 2.1-2.4 billion in 2024.
• It is projected to reach USD 3.8-4.2 billion by 2034,
• Representing a CAGR of 6-7% over the forecast period.
Growth is driven by:
• Rising aneurysm detection rates due to greater use of MRI/CTA
• Increasing stroke burden and aging populations
• High adoption of endovascular technologies
• Expansion of specialized neurocritical-care centers
• Improved reimbursement for minimally invasive neurosurgery
Key Players
The market consists of neurosurgery device manufacturers, neuro-ICU monitoring companies, and pharma companies supplying vasospasm and anticoagulant-reversal therapies. Key participants include:
• Medtronic
• Stryker
• Johnson & Johnson (DePuy Synthes / Cerenovus)
• Penumbra
• Terumo Corporation
• Integra LifeSciences
• MicroPort Scientific
• Canon Medical & Siemens Healthineers (imaging)
• Companies producing nimodipine and other vasospasm-prevention therapies
These players dominate through offerings such as embolization coils, flow-diversion stents, microcatheters, aneurysm clips, neurovascular access systems, ICU monitors, and SAH-related pharmaceuticals.
Market Segmentation and Growth Insights
By Treatment Approach
Endovascular Coiling (Largest Segment)
• Now considered the preferred intervention for many ruptured aneurysms.
• Strong year-on-year growth due to shorter recovery time and wider availability of neurointerventionalists.
Flow-Diversion and Stent-Assisted Techniques (Fastest Growing Segment)
• Used for complex or wide-neck aneurysms.
• High-value devices with strong adoption in advanced centers.
Surgical Clipping
• Still significant for certain aneurysm types or when endovascular access is limited.
• Stable but slower-growth compared to minimally invasive options.
Medical Management
• Includes vasospasm prevention drugs (e.g., nimodipine), blood-pressure management, anticoagulation reversal, and anti-inflammatory agents.
• Moderate growth driven by ICU protocol modernization.
Critical Care Monitoring Systems
• ICP monitors, brain oxygenation monitors, transcranial Doppler devices.
• Increasingly adopted as neuro-ICU standards improve worldwide.
By Cause
• Aneurysmal SAH (dominant share): Highest demand for surgical/endovascular intervention and prolonged ICU care.
• Traumatic SAH: Increasing incidence from road accidents and falls; primarily ICU-driven spending.
• Other non-aneurysmal SAH: Smaller but relevant share.
By End User
• Comprehensive stroke centers and tertiary hospitals
• Neurosurgery and neurointerventional units
• Intensive care units with neuro-ICU specialization
• Diagnostic imaging centers
Hospitals with hybrid operating rooms and 24/7 neurointerventional capability represent the fastest-growing customer segment.
Regional Insights
North America
• Leading market with highest adoption of endovascular coiling, flow-diversion devices, and advanced neuro-ICUs.
• Strong reimbursement and large stroke patient volumes.
Europe
• Mature neurosurgical systems with broad access to diagnostic imaging and clipping/coiling procedures.
• Consistent demand across major EU countries.
Asia-Pacific
• Fastest growth due to rapidly expanding healthcare infrastructure, high population density, rising hypertension prevalence, and emerging stroke centers in China, India, and Southeast Asia.
Latin America & Middle East/Africa
• Growing adoption of minimally invasive neurosurgery and ICU upgrades but limited by resource constraints.
Explore Full Report here: https://exactitudeconsultancy.com/reports/72076/subarachnoid-hemorrhage-market
Key Market Drivers
• Rising number of ruptured cerebral aneurysms due to aging and lifestyle risk factors
• Increased MRI/CTA screening, enabling earlier aneurysm detection
• Technological advancements in coils, stents, microcatheters, and navigation systems
• Greater investment in stroke centers and neuro-ICU capabilities
• Improved survival rates, enlarging the treated patient population
• Favorable policies supporting rapid stroke intervention protocols
• Increasing number of neurosurgeons trained in endovascular techniques
Conclusion
The Subarachnoid Hemorrhage Market is transitioning into a high-technology neurosurgical segment with steady global expansion. With:
• Market size of USD 2.1-2.4 billion in 2024,
• Expected to grow to USD 3.8-4.2 billion by 2034,
• And a CAGR of 6-7%,
the sector is poised for long-term growth driven by advanced endovascular devices, early diagnosis, and improved neurocritical care.
Companies that invest in:
• Next-generation flow diverters and embolization systems
• AI-powered imaging and rapid triage tools
• Neuro-ICU monitoring innovations
• Training and integrated stroke-care solutions
will be best positioned to lead this market over the next decade.
This report is also available in the following languages : Japanese (くも膜下出血市場), Korean (지주막하출혈 시장), Chinese (蛛网膜下腔出血市场), French (marché de l'hémorragie sous-arachnoïdienne), German (Markt für Subarachnoidalblutungen), and Italian (Mercato dell'emorragia subaracnoidea), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/request-sample/72076
Our More Reports:
Intracranial Hemorrhage Clinical Market
https://exactitudeconsultancy.com/reports/73653/intracranial-hemorrhage-clinical-market
Von Willebrand Disease (VWD) Market
https://exactitudeconsultancy.com/reports/71718/von-willebrand-disease-vwd-market
Aneurysmal Subarachnoid Hemorrhage (SAH) Market
https://exactitudeconsultancy.com/reports/71895/aneurysmal-subarachnoid-hemorrhage-sah-market
Intracerebral Hemorrhage Market
https://exactitudeconsultancy.com/reports/71943/intracerebral-hemorrhage-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Subarachnoid Hemorrhage (SAH) Market Expands as Minimally Invasive Neurosurgery, Advanced Diagnostics, and Critical-Care Therapies Improve Survival here
News-ID: 4302735 • Views: …
More Releases from Exactitude Consultancy
Transient Ischemic Attack (TIA) Market Grows as Early Diagnosis, AI-Enabled Stro …
The Transient Ischemic Attack (TIA) Market is transforming as healthcare systems shift focus from delayed stroke management to rapid TIA triage and prevention. With TIAs serving as a critical early warning sign for major strokes, demand for advanced diagnostics, AI-assisted imaging, emergency care pathways, and secondary-prevention drugs is increasing worldwide. The next decade will be defined by precision risk assessment, accelerated imaging, and a global push to reduce preventable strokes.
Download…
Spasticity Market Strengthens as Oral Agents, Botulinum Toxins, and Intrathecal …
The global Spasticity Market is shifting from basic symptomatic relief toward structured, multi-modal management. Neurologists, rehabilitation physicians, and surgeons are increasingly combining oral antispastic agents, focal botulinum toxin injections, advanced intrathecal drug delivery, and intensive neurorehabilitation to preserve mobility and independence. As prevalence of neurological disorders climbs worldwide, demand for safe, long-term spasticity control is rising in both high-income and emerging markets.
Download Full PDF Sample Copy of Market Report @…
Secondary Progressive Multiple Sclerosis (SPMS) Drug Market Grows as Oral S1P Mo …
The Secondary Progressive Multiple Sclerosis (SPMS) drug market is entering a more innovation-rich phase. As better diagnostics and longer survival increase the number of patients transitioning from relapsing-remitting MS (RRMS) to SPMS, demand is rising for therapies that slow disability progression, not just reduce relapses. Oral S1P modulators like siponimod, high-efficacy monoclonal antibodies, and late-stage BTK inhibitors are reshaping the treatment landscape and expanding the value of the SPMS segment…
Primary Progressive Aphasia (PPA) Market Accelerates as Speech Therapies, Digita …
The Primary Progressive Aphasia (PPA) market, once an overlooked niche within dementia care, is becoming a focused, innovation-driven segment. As diagnosis improves and frontotemporal dementia (FTD) research expands, demand is rising for structured speech therapy programs, digital communication platforms, assistive technologies, and participation in disease-modifying drug trials. Over the next decade, PPA will increasingly be managed as a distinct, treatable neurodegenerative syndrome rather than a generic "atypical dementia" label.
Download Full…
More Releases for ICU
Key ICU Beds Market Trend for 2025-2034: High Cost Of Icu Beds Hinders The Marke …
What Is the Future Outlook for the ICU Beds Market's Size and Growth Rate?
In the last few years, there has been significant growth in the market size of ICU beds. The market, which stood at $2.1 billion in 2024, is predicted to increase to $2.23 billion in 2025, with a compound annual growth rate (CAGR) of 6.1%. Factors contributing to this past growth include an aging population, advancements in technology,…
Remote ICU Monitoring Software Market | Advanced ICU Care, Advanced ICU Care, Ap …
The global remote icu monitoring software market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the remote icu monitoring software market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving…
Virtual ICU Market - Unleashing the Power of Technology: Virtual ICU Redefining …
Newark, New Castle, USA - Growth Plus Reports has published a new report on Virtual ICU Market, which includes a detailed analysis based on competitors and important market segments (2023-2031). The Global Virtual ICU provides a thorough analysis of many segments such as opportunities, market size, developments, innovation, sales, and overall growth of leading players. The research is based on primary and secondary statistical data, and it includes both intuitive…
ICU Beds Market Size to Hit $2,219.3 Million by 2028 | ICU Beds Industry Forecas …
Market Overview:
According to our experience research team, ICU Beds Market was valued at USD 1,593.8 Million in 2021, and the global ICU Beds industry is projected to reach a value of USD 2,219.3 Million by 2028, at a CAGR of 5.1% during the forecast period 2022-2028
Vantage Market Research is a collection of market research studies on several industries, such as Chemicals, semiconductors & Electronics, Food & Beverages Technology, Energy &…
Global Tele-ICU Market: Emerging Trends, Major Key Players Advanced ICU Care and …
According to the report, The global tele-intensive care unit market size was valued at USD 1.8 billion in 2018 and is expected to witness a CAGR of 16.7% over the forecast period.
Request Free Sample Report or PDF Copy: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=007091
The latest research report published by Evolve Business Intelligence examines the impacts of numerous market aspects on the global TELE-ICU industry including a look at the current market size and forecasts…
Global Tele-ICU Market: Emerging Trends, Major Key Players Advanced ICU Care and …
According to the report, The global tele-intensive care unit market size was valued at USD 1.8 billion in 2018 and is expected to witness a CAGR of 16.7% over the forecast period.
Request Free Sample Report or PDF Copy: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=007091
The latest research report published by Evolve Business Intelligence examines the impacts of numerous market aspects on the global TELE-ICU industry including a look at the current market size and forecasts…
